Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TK1 | P04183 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.42 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25216050 | 1.00 | LMNA (0.53) | LMNATK1PTGS1TDP1TSHR | |
| SCHEMBL15869143 | 0.95 | LMNA (0.58) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL28158506 | 0.95 | LMNA (0.58) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL15869126 | 0.95 | LMNA (0.58) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL29080212 | 0.89 | LMNA (0.59) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL29080210 | 0.89 | LMNA (0.59) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL31678497 | 0.86 | ESR1 (0.50) | LMNATK1TDP1TSHRMAPK1 | |
| SCHEMBL8078151 | 0.86 | TDP1 (0.61) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL8522570 | 0.86 | TDP1 (0.61) | LMNATK1TDP1TSHRSLC6A3 | |
| SCHEMBL8522569 | 0.86 | TDP1 (0.61) | LMNATK1TDP1TSHRSLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016727-A1 | LEAVE-ON COMPOSITION | FIRMENICH & CIE (CH) | 2024-01-18 | — | — | US | disclosed |
| CN-116406251-A | Disposable composition | 弗门尼舍有限公司 | 2023-07-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016727-A1 | LEAVE-ON COMPOSITION | CUTA, DPM1, TYR | LMNA 329/4885TK1 3047/4885PTGS1 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.